High-dose methotrexate for patients with osteosarcoma in resource-poor settings
BACKGROUND: Methotrexate (MTX) is one of the most widely used antifolate analogs. It is active against both hematological and solid tumors. Healthcare providers are reluctant to use high-dose MTX (HDMTX) on patients in various institutions, especially in resource-poor settings. Not much data are ava...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wolters Kluwer Medknow Publications
2026-07-01
|
| Series: | Annals of Oncology Research and Therapy |
| Assuntos: | |
| Acceso en liña: | https://journals.lww.com/10.4103/aort.aort_39_25 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|